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Abstract
Rationale: Several epidemiological studies associated exposure to increased levels of particulate matter in
Augsburg, Germany with cardiovascular mortality and morbidity. To elucidate the mechanisms of cardiovascular
impairments we investigated the cardiopulmonary responses in spontaneously hypertensive rats (SHR), a model for
human cardiovascular diseases, following intratracheal instillation of dust samples from Augsburg.
Methods: 250 μg, 500 μg and 1000 μg of fine ambient particles (aerodynamic diameter <2.5 μm, PM2.5-AB)
collected from an urban background site in Augsburg during September and October 2006 (PM2.5 18.2 μg/m
3,
10,802 particles/cm
3) were instilled in 12 months old SHRs to assess the inflammatory response in bronchoalveolar
lavage fluid (BALF), blood, lung and heart tissues 1 and 3 days post instillation. Radio-telemetric analysis was
performed to investigate the cardiovascular responses following instillation of particles at the highest dosage based
on the inflammatory response observed.
Results: Exposure to 1000 μgo fP M 2.5-AB was associated with a delayed increase in delta mean blood pressure
(ΔmBP) during 2
nd-4
th day after instillation (10.0 ± 4.0 vs. -3.9 ± 2.6 mmHg) and reduced heart rate (HR) on the 3
rd
day post instillation (325.1 ± 8.8 vs. 348.9 ± 12.5 bpm). BALF cell differential and inflammatory markers
(osteopontin, interleukin-6, C-reactive protein, and macrophage inflammatory protein-2) from pulmonary and
systemic level were significantly induced, mostly in a dose-dependent way. Protein analysis of various markers
indicate that PM2.5-AB instillation results in an activation of endothelin system (endothelin1), renin-angiotensin
system (angiotensin converting enzyme) and also coagulation system (tissue factor, plasminogen activator
inhibitor-1) in pulmonary and cardiac tissues during the same time period when alternation in ΔmBP and HR have
been detected.
Conclusions: Our data suggests that high concentrations of PM2.5-AB exposure triggers low grade PM mediated
inflammatory effects in the lungs but disturbs vascular homeostasis in pulmonary tissues and on a systemic level
by affecting the renin angiotensin system, the endothelin system and the coagulation cascade. These findings are
indicative for promotion of endothelial dysfunction, atherosclerotic lesions, and thrombogeneis and, thus, provide
plausible evidence that susceptible-predisposed individuals may develop acute cardiac events like myocardial
infarction when repeatedly exposed to high pollution episodes as observed in epidemiological studies in
Augsburg, Germany.
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Epidemiological studies have linked ambient particulate
matter (PM) levels to an increased incidence of adverse
cardiovascular events. The World Health Organization [1]
reported that over 800,000 premature deaths worldwide
per year can be attributed to PM air pollution [1]. Numer-
ous epidemiological studies have linked short-term and
long-term PM exposures to increased mortality [2-5].
An analysis by Pope et al. [6] indicated that with every
10 μg/m
3 increase in atmospheric PM2.5, cardiopulmonary
mortality increased by 6%. For a similar increase in PM2.5,
it has been shown that there is a 2.1% increase in the
number of deaths related to ischemic heart disease [7].
Short-term increases in PM exposure elevate the incidence
of ischemic cardiac disease and congestive cardiac failure
with specific pathophysiological end points like myocardial
infarction, arrhythmias, reduced heart-rate variability
(HRV), and elevated heart rate (HR) in adults [5,8-12].
Inhalation of PM may cause pulmonary inflammation
characterized by neutrophil and macrophage activation
[13-16] associated with a subsequent systemic inflamma-
tory response and the disturbance of endothelial function
and activation of the blood coagulability [15-19]. Repeat-
edly, PM was associated with an increase in serum levels
of C-reactive protein, the classical acute phase reactant
indicative for a systemic inflammatory response which is
considered to be a risk factor for cardiovascular diseases
[7,15,20,21]. However, the underlying pathophysiological
mechanisms of airborne PM2.5 mediated cardiopulmonary
mortality and morbidity are complex and remain to a
large extent unexplored.
Several epidemiological studies on PM associated car-
diovascular effects were conducted in Augsburg, a med-
ium sized city located in Southern Germany with about
250,000 inhabitants and no heavy industry, by using the
‘Cooperative Health Research in the Region of Augsburg
(KORA)’ platform. In January 1985, an air pollution epi-
sode occurred throughout Central Europe [22] resulting
in an increase of hospital admissions for cardiovascular
diseases, such as acute coronary syndromes and arrhyth-
mias [23]. The first MONICA survey (MONItoring of
trends and determinants in Cardiovascular disease) was
carried out in Augsburg during that winter period
which included the days of the pollution episode [24].
Peters et al [20] reported that PM in the Augsburg
atmosphere may have induced systemic inflammation as
suggested by increased C-reactive protein levels and
increased plasma viscosity [17]. In several epidemiologi-
cal studies, exposure to Augsburg dust was associated
with an increase in HR [9], arterial BP and an altered
autonomic control [25] as well as the increased inci-
dences of myocardial infarction among susceptible per-
sons [[5,26]; Figure 1). Since 1985 exposure to airborne
PM has changed in Augsburg mainly due to modified
emissions of combustion sources. It continues to pose
threat to the population in Augsburg for various align-
ments mainly cardiopulmonary disorders.
Therefore investigations on the causative pathome-
chanism for cardiovascular diseases due to PM exposure
will help immensely in understanding the molecular phe-
nomenon and support preventive, such as creation of low
emission zones, or curative strategies. To address the
potential underlying pathomechanism for PM associated
cardiovascular diseases, spontaneously hypertensive rats
(SHRs; 12 months), a well established animal model of
human cardiovascular disease were exposed to PM2.5-AB
collected during September and October 2006 by intra-
tracheal (i.t.) instillation and assessed for cardiopulmon-
ary responses, its temporal assignment, and its potential
molecular basis. We hypothesized that either by direct
particle-cell interaction or by inflammatory responses in
the lungs and/or on the systemic level exposure to
PM2.5-AB induces markers of endothelial dysfunction
which promotes a pro-coagulatory state and may induce
areteriosclerotic lesions. Exposure also affects the vasore-
gulatory homeostasis by affecting the endothelin and the
renin-angiotensin system (RAS) resulting in an increased
arterial BP which ultimately contribute to an increased
afterload and oxygen demand of the heart. We expect
effects of a single exposure to be small and, taken as a
unique event, to be clinically of minor importance in sub-
jects with sufficient cardiovascular reserves. However,
repeated exposures over several years as given in the
environmental setting of Augsburg is supposed to pro-
mote cardiovascular disorders and eventually contribute
to trigger fatal cardiac events in susceptible subjects such
as myocardial infarction documented in the epidemiolo-
gical studies. In the present study we focused on the
acute response detectable within 5 days after a single
instillation of PM2.5-AB and analysed a panel of protein
markers assessing vasoregulatory pathways (Endothelin-
1, RAS) and markers indicative for coagulation and ather-
osclerosis (PAI-1;TF; VCAM-1) and angiogenesis
(VEGF). Our findings provide evidence for plausible
molecular mechanisms underlying low grade PM2.5-AB
mediated inflammatory effects and alterations of the vas-
cular homeostasis. We could show that a single exposure
of SHRs to PM2.5-AB induces a slight inflammatory
response in pulmonary and systemic tissues,i n c l u d i n g
activation of the endothelial and vasoregulatory system
and promotion of a pro-coagulatory state. This may con-
tribute to the development of cardiovascular disorders
and to cardiac events in susceptible persons as observed
in epidemiological studies in Augsburg (Figure 1).
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SHR were intra tracheally (i.t.) instilled with ambient
PM2.5 collected from Augsburg, Germany, and were
assessed for cardiophysiological response using radio tele-
metry on 5 consecutive days post exposure. To assess
inflammatory responses in the lung and on a systemic
level standard bronchoalveolar lavage fluid (BALF), blood
samples, and tissue samples from heart and lung were
obtained on day 1 and 3 after instillation. Histopathologi-
cal studies were carried out in lung and heart. Protein
concentrations of various inflammatory markers were
measured in BALF, lung and heart. Focused analysis of
biomarkers (at protein level) associated with hypertension
(angiotensin converting enzyme: ACE), endothelial activa-
tion (endothelin-1: ET-1), coagulation factors (tissue fac-
tor: TF; plasminogen activator inhibitor-1: PAI-1),
atherosclerosis (vascular cell adhesion molecule 1:
VACM-1) and angiogenesis (vascular endothelial growth
factor: VEGF) was performed from the lung and heart.
Sham (water/vehicle) instilled animals served as control.
Cardiovascular response assessed by radio telemetry
To address the PM2.5-AB induced cardiovascular response
a well established animal model (spontaneously hyperten-
sive rats, SHRs) of human cardiovascular disease has been
used in the present study. All animals (SHRs; 12 months)
showed clear signs of cardiovascular disease at the time of
investigation. Mean blood pressure (mBP) of unexposed
rats ranged between 169 and 208 mmHg and mean heart
weight between 1463 and 2112 mg, thus, being substan-
tially elevated compared to non-hypertensive WKY rats
[27,28]. Despite being kept under identical housing condi-
tions the extent of hypertension and its effects on second-
ary organs varied between animals. The animals were
randomly assigned to the control or exposure group,
respectively.
Figure 2 summarizes effects on the cardiovascular sys-
tem following instillation of 1000 μgo fP M 2.5-AB. After
PM2.5-AB exposure no significant differences between
control and exposed animals were detectable for absolute
values of mBP (Figure 2a). However, the interpretation of
mBP data based on absolute values is limited in this case
because baseline data were 9% lower in exposed than in
control animals (exposed: 181.1 ± 4.8 mmHg versus con-
trol: 197.0 ± 2.8 mmHg, p < 0.02). Differences in mBP
were due to a moderate changes in systolic (exposure:
199.6 ± 4.0 mmHg versus control: 226 ± 2.5 mmHg) and
diastolic (exposure: 162.5 ± 6.1 mmHg versus control/
168 ± 3.1 mmHg) BP. Therefore, individual mBP differ-
ences (ΔmBP) were calculated from post exposure values
Figure 1 The figure illustrates the rationale of experimental study evolving from the epidemiological findings.
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mary statistics for the analysis of repeated measurements
(AUC statistics) revealed that differences in control ani-
mals varied randomly between -3.8 ± 1.5 mmHg (day 2
post exposure) and +2.0 ± 1.6 mmHg (day 1 post expo-
sure) while those observed in exposed animals increased
with a lag of 1 day and peaked on post exposure day 4
(+10.0 ± 4.0 mmHg, p < 0.05). Delta mBP differences
between groups were significant on day 2 and 4 post
exposure (p < 0.04, paired t-test). Equivalent changes
were observed on day 3, although statistically not signifi-
cant (p < 0.1, paired t-test). Delta mBP declined and
reached almost baseline values on post exposure day 5
(6.2 ± 5.8 mmHg; not significant).
Baseline measurements of HR revealed comparable
values between both groups, i.e. 351.6 ± 5.7 and 352.8 ±
9.4 in control and exposed animals, respectively (Figure
2c, not significant). Absolute HR values responded with
a lag of 1 day to PM2.5-AB exposure and were signifi-
cantly lower in the exposure group by 6% (325.1 ± 8.8
bpm vs 348.9 ± 12.5 bpm, p < 0.03) on the 3
rd post
exposure day. However, applying the same statistical
approaches as used for mBP neither the area under the
curve nor differences in HR values (Figure 2d) reached
the level of statistical significance.
The standard deviation of all normal adjacent sinus
intervals (SDNN), a measure of the overall heart-rate
variability (HRV), the square root of the mean of
squared differences between adjacent normal to normal
intervals (RMSSD) and the low-frequency to high-fre-
quency ratio (LF/HF) remained unaffected in exposed
SHRs compared to their control (Figure 2e).
Acute pulmonary inflammatory response
BALF and lung: Typically for SHRs, elevated cell numbers
were detected compared to healthy rats [29]. Intratracheal
Figure 2 Mean blood pressure (mBP, 2a); Changes in individual mean blood pressure (delta mBP, 2b).; Heart rate (HR, 2c); Changes in
individual heart rate (delta HR, 2d); and Changes in time domain and frequency domain measures of heart rate variability (HRV, 2e)
in sham (control) or Augsburg particulate matter (PM2.5-AB, exposed) instilled SHRs. The vertical bars exhibit arithmetic mean values
(mean ± SE) of sham (white; n = 5) and exposed (black; n = 5) groups. The summary statistics for the analysis of repeated measurements
revealed that delta mBP differences between groups were significant on day 2 and 4 post exposure (p < 0.04). Delta mBP declined and reached
almost baseline values on day 5. Absolute HR values responded with a lag of 1 day to PM2.5-AB exposure and were significantly lower in the
exposure group by 6% (325.1 ± 8.8 bpm vs 348.9 ± 12.5 bpm, p < 0.03) on the 3
rd day after instillation. The summary statistics for the analysis of
repeated measurements revealed that neither the area under the curve nor differences in HR values reached the level of statistical significance.
In Figure 2e each bar represents a combined mean value of: 12 5-minutes segments/12-h dark period/rat) from 5 rats. SDNN: standard deviation
of normal to normal (NN) intervals. RMSSD: square root of the mean of squared differences between adjacent NN intervals. LF/HF: ratio of the
absolute powers in the low-frequency (LF: 0.20 Hz to 0.75 Hz) and high-frequency bands HF: 0.75 Hz to 2.5 Hz). * indicates significant difference
of (p < 0.04: BP; p < 0.03: HR) between exposed (black) and sham (white) SHRs.
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BALF derived inflammatory cells at day 1 post instillation
(Figure 3a). Dose dependent increases in macrophages
(Figure 3b), polymorphonuclear leukocytes (PMNs) (Fig-
ure 3c), and lymphocytes (Figure 3d) occurred in on day 1
(24 h) in 500 μg and 1000 μgP M 2.5-AB exposed animals.
T h et o t a ll a v a g a b l ec e l l s ,e s p e c i a l l yt h eP M 2.5-AB asso-
ciated influx of PMN and lymphocytes were largely
reversed by day 3 (72 h) and reached baseline values. At
the exposure dose of 250 μg total lavageable cells and cell
differentials did not exhibit any significant difference com-
pared to sham.
To characterize the degree of inflammatory changes in
the lung at a molecular level, we analyzed key inflamma-
tory markers [30] at protein level (IL-6 and osteopontin;
Figures 4a-b) from BALF and lung homogenate (macro-
phage inflammatory protein-2/MIP-2 and tumor necro-
sis factor alpha/TNF-a; Figure 4c). IL-6 was induced by
2.5 fold and 4.0 fold (p < 0.05; Figure 4a) in the BALF
on day 1 post instillation of 500 μg and 1000 μgP M 2.5-
AB, respectively, compared to sham. Osteopontin con-
centration in BALF was significantly increased by 2.0
fold only at the highest dose (1000 μg; p < 0.05; Figure
4 b )c o m p a r e dt os h a ma td a y1p o s ti n s t i l l a t i o n .B o t h
IL-6 and osteopontin concentrations were reversed by
day 3 and reached near to baseline values.
C o n c e n t r a t i o n so fM I P 2i nt h el u n gw e r eo n l ys l i g h t l y
affected (Figure 4c). Intratracheal instillation of 1000 μg
PM2.5-AB significantly increased the MIP-2 (1.3 fold;
p < 0.05) concentration at the day 1 and 3 post instillation
Figure 3 Total lavagable cells (2a), absolute macrophage (2b), polymorphonuclear leukocytes (PMN; 2c) and lymphocytes (2d)
numbers of brcheoalveolar lavage fluid (BALF) obtained from sham (control) and Augsburg particulate matter (PM2.5-AB, exposed)
instilled SHRs. Dose (250 μg to 1000 μg) and time dependent changes on day 1 and 3 (24 h and 72 h after instillation) are displayed. Bars
represent arithmetic mean values ± SE of sham (n = 6) and exposure groups (n = 6). †: Significantly (p < 0.05) higher than 250 μg exposed at
24 h *: Significantly (p < 0.05) higher than sham and 250 μg exposed at 24 h.
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Page 5 of 20Figure 4 Response of pulmonary inflammation markers in the bronchoalveolar lavage fluid (BALF). Concentrations of Interleukin-6 (IL-6)
(3a), osteopontin (3b), and macrophage inflammatory protein-2 (MIP-2) in lung homogenate (3c) following intratracheal (i.t.) instillation of sham
and Augsburg particulate matter (PM2.5-AB, exposed) in SHRs are shown. Bars represent arithmetic mean values ± SE of sham (n = 6) and
exposure groups (n = 6). IL-6 exhibited a typical dose-time response in the BALF. Osteopontin in the BALF and MIP-2 in the lung homogenate
(3c) was affected only at the highest dose (1000 μg). *: Significantly (p < 0.05) higher than sham and 250 μg exposed at 24 h **: Significantly
(p < 0.05) higher than sham and exposed at day 1. †: Significantly (p < 0.05) higher than 500 μg exposed at day 1 and 3.
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but was not significantly affected compared to sham.
TNF-a expression was not significantly altered in any of
the doses (data not shown).
Pulmonary histopathology
Pulmonary histopathological analysis by light micro-
scopy examination of representative lung sections
revealed moderate accumulation of mononuclear cells in
the lungs due to the advanced cardiovascular state of
the animals [29,31]. A slight inflammatory response with
some PMN influx and particle-laden macrophages, were
detectable at high doses of PM2.5-AB (Figure 5i and 5j).
There were no signs of PM2.5-AB induced lung injury,
even at the highest dose applied.
Systemic inflammatory response
Acute phase response To assess whether PM2.5-AB
instillation induces an inflammatory response at the
systemic level, serum levels of the “acute phase reac-
tant”, C-reactive protein (CRP) was determined. A
clearly delayed increase of CRP was observed in a
dose-dependent manner (Figure 6a) with a 4.4 fold
induction of CRP on day 3 following instillation of
1000 μgP M 2.5-AB (p < 0.05) and a 2.4 fold induction
at 500 μg (p < 0.05). At day 1 CRP was not affected
after 500 μgP M 2.5-AB albeit slightly but significantly
(1.6 fold; p < 0.05) increased after instillation of 1000
μg compared to sham.
Haematology The complete blood cell count, i.e. total
red (haematocrit) and white blood cells, (platelets, neu-
trophils and lymphocytes) was assessed on 1
st and 3
rd
day after instillation and revealed no alterations between
sham and exposed animals.
Cardiac tissue A delayed gradual induction of osteo-
pontin and MIP-2 was observed in cardiac tissue
(Figures 6b and 6c). Osteopontin was significantly
induced by 2.4 fold only at the highest dose (1000 μg;
Figure 6b; p < 0.05) on day 3 post instillation. MIP-2
reflected a similar response as it is observed in the pul-
monary tissue. At 1000 μgP M 2.5-AB MIP-2 was signifi-
cantly induced by 1.5 fold at day 1 and by 2 fold (p <
0.05; Figure 6c) at day 3 compared to sham. TNF-a was
not affected (data not shown).
PM2.5 mediated effects on vascular homeostasis
Pulmonary protein analysis
ACE, ET-1, TF, PAI-1, VACM-1 and VEGF protein con-
centrations were assessed from lung tissues of PM2.5-AB
exposed SHRs on day 1 and day 3 post instillation (Fig-
ures 7a-f; see Table 1). ET1, and TF were significantly
reduced by about 35% (1.5 fold repression, p < 0.05) at
both PM2.5-AB concentrations and did not recover over
the time period of investigation. ACE was affected only at
the highest concentration (1000 μg). ACE levels
decreased to about 75% of its activity (1.3 fold repression,
p<0 . 0 5 )a td a y1a n de x h i b i t e da ne v e ns t r o n g e r
decrease to about 35% (3 fold repression, p < 0.05) on
day 3. PAI-1 (1.5 fold) and VCAM-1 (1.3 fold) were sig-
nificantly (p < 0.05) increased following instillation of
500 μgo fP M 2.5-AB on day 1, while VEGF was signifi-
c a n t l yi n d u c e d( 1 . 5f o l d ;p<0 . 0 5 )o n l ya tt h eh i g h e s t
dose (1000 μg) compared to sham. For PAI-1 an initial
increase was not detected at the highest concentration
but on day 3 a strong reduction at both 500 and 1000 μg
of PM2.5-AB to 40% and 15%, respectively (2.4 and 6.5
fold repression, respectively, p < 0.05) was observed.
Cardiac protein analysis
The markers assessed in lung were also measured in the
heart tissue at day 1 and 3 after instillation (Figures 7a-f;
see Table 1). ACE was induced by 1.4 fold at 1000 μg
(p < 0.05) on day 1 and 3 post instillation compared to
sham. Similarly, ET-1 was significantly induced by 1.5
fold (p < 0.05) on day 1 and 3 following instillation of
1000 and 500 μgo fP M 2.5 compared to sham. At 1000 μg
of PM2.5-AB on day 3 post instillation ET-1 was induced
by 2.1 fold (p < 0.05). On day 3 post instillation almost
2 fold (p < 0.05) elevated concentrations of PAI-1 and TF
were detected. VCAM-1 was induced by 1.6 (p < 0.05)
fold at 1000 μgo fP M 2.5-AB compared to sham. VEGF
was not affected in the heart tissue. As evident, in con-
trast to the pulmonary response most of these markers
exhibit a delayed induction in the cardiac tissue with
time (day 3 post instillation) matching the cardiophysio-
logical alterations.
Cardiac histopathology
No signs of inflammation or cardiomyopathy following
instillation of ambient particle could be detected by his-
tological analysis (data not shown).
Discussion
Epidemiological studies have identified exposure to ele-
vated concentrations of ambient PM as a risk factor for
the exacerbation of ischemic heart disease and congestive
heart failure [32,33]. Epidemiological findings in the
region of Augsburg, Germany, showed that elevated
levels of PM are associated with an increased incidence
of myocardial infarction [5,26] and also with increased
levels of markers indicative for early systemic effects, like
CRP and IL-6, or with plasma viscosity [9,17,20,26,34].
Therefore, it becomes apparent that air pollution events
in Augsburg influence cardiopulmonary physiology.
Hence, the authors propose that a PM induced low
grade, sustained systemic inflammation and modulation
of the autonomic function of the heart and the vasomo-
tor activity are potential underlying mechanisms for fatal
cardiac event as also suggested by several other epide-
miological studies [5,9,10,17,25,26]. As the selections of
epidemiological cohorts in most cases are random, the
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Page 7 of 20Figure 5 Lung histology from control and exposed rats. Light microscopy examination of representative lung sections from sham (a-b) and
exposed rats 24 hours after 250 μg (c-d), 500 μg (e-f), or 1000 μg (g-j) PM2.5-AB instillation, respectively. Light microscopy examination at higher
magnification revealed PM-laden macrophages after instillation of 1000 μgP M 2.5 Figures 3i and j show two different microscopic fields.
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Page 8 of 20Figure 6 Response of the systemic Inflammatory marker C-reactive protein (CRP) in the serum (3a), and of osteopontin (3b) and
macrophage inflammatory protein 2/MIP-2 (3c) in the heart following intratracheal instillation of sham and Augsburg particulate
matter (PM2.5-AB, exposed) in spontaneously hypertensive rats (SHRs). Bars represent arithmetic mean values ± SE of sham (n = 6) and
exposure groups (n = 6). A delayed increase of CRP was observed in a dose-dependent manner whereas osteopontin and MIP2 were induced
only at the highest dose. *: Significantly (p < 0.05) higher than sham, 250 μg and 500 μg exposed at day 1. **: Significantly (p < 0.05) higher
than sham and exposed at day 1. ‡: Significantly (p < 0.05) higher than sham and exposed at day 1 and 3. †: Significantly (p < 0.05) higher than
500 μg exposed at day 1. ††: Significantly (p < 0.05) higher than sham and 500 μg exposed at both day 1and 3.
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Page 9 of 20Figure 7 Side by side comparison of the lung and heart response of angiotensin converting enzyme (ACE; 5a), Endothelin-1 (ET-1;
5b), plasminogen activator inhibitor-1 (PAI-1; 5c), tissue factor (TF; 5d), vascular cell adhesion molecule-1(VCAM-1; 5e) and vascular
endothelial growth factor (VEGF; 5f) following intratracheal instillation of sham and Augsburg particulate matter (PM2.5-AB, exposed)
in spontaneously hypertensive rats (SHRs). Bars represent arithmetic mean values ± SE of sham (n = 6) and exposure groups (n = 6). †:
Significantly (p < 0.05) lower than sham. ††: Significantly (p < 0.05) lower than sham and exposed at both day 1 and 3. *: Significantly (p < 0.05)
higher than sham. **: Significantly (p < 0.05) higher than sham and 500 μg exposed at day1 both day 1 and 3. ￿: Significantly (p < 0.05) higher
than 500 μga t2 4h .￿￿: Significantly (p < 0.05) higher than sham and 500 μg at day 1. ‡: Significantly (p < 0.05) higher than sham and exposed
at day 1 and 3.
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study in survivors of myocardial infarction, by Peters et
al. (26,10) has reported that transient exposure to traffic
may increase the risk of myocardial infarction. Myocar-
dial infarction is an acute event predisposed due to
chronic physiological impairment, like atherosclerotic
lesions, a pro-coagulatory state and increased plasma
viscosity. Therefore, in this work the experimental design
was to study PM2.5-AB induced pathways potentially
associated with the preceding cardiovascular events that
eventually contribute to the observed fatal outcomes
reported by epidemiology (Figure 8). In a first approach
we focused on the acute response after a single instilla-
tion of moderate to high PM2.5-AB concentrations in the
range of doses applied in other studies [35,36] supposed
to cover the range of “no effects” to “obvious response”
but being beyond the level of lung injury as shown by
biological markers and histological examinations. To
identify PM2.5-AB induced pathways we investigated two
issues in a well established animal model (spontaneously
hypertensive rats) of human cardiovascular disease: a) the
dose-time dependent inflammatory response of PM2.5-
AB in the lungs, on a systemic level and the target organ
heart complemented by analysis of the cardiovascular
performance by radiotelemetry and b) potential patho-
physiological mechanisms affecting the cardiopulmonary
system following PM2.5-AB exposure (Figure 8). We ana-
lysed all biomarkers at the protein level compared to
mostly transcript based assessments in other studies.
High volume filter samples of ambient Augsburg dust
were taken during September and October 2006 at an
urban background site in Augsburg. This location has
been carefully selected by comparing PM burdens at dif-
ferent urban background sites to find out a representative
measurement site for Augsburg [37]. Moreover, since
2004 different online measurement methods were estab-
lished at this site to characterize the physical and chemi-
cal properties of ambient Augsburg dust [38-43]. The
main PM sources in urban areas are of anthropogenic
origin and therefore a mixture of different particulate
emissions like traffic, domestic heating and small-scale
industry will be expected. Chemical analysis of PM from
Augsburg urban area reported the presence of anthropo-
genic polycyclic aromatic hydrocarbons (PAH) and their
oxidised derivatives (O-PAH).The online measurements
during the sample period suggests a moderate PM expo-
sure. For example, the PM2.5 mass concentration was
19.8 and 18.2 μg/m
3 for the mean of the sample period.
Traffic is well-known as an emission source of particle
number concentration especially of ultrafine particles
[39]. In our study the ultrafine particles concentrations
were 10344 and 10802 1/cm
3 for the mean of the sample
period. The applied sample and resuspension technique
(reference method of US-EPA) provided PM and the
water soluble organic and inorganic constituents from
ambient Augsburg PM to the rat lungs by instillation.
Although the sampled PM2.5 includes the ultrafine parti-
cles fraction it is unlikely that sampling and preparation
keeps ultrafine particles in its “airborne state” rather
ultrafine particles may form aggregates with itself or fine
particles but they may keep their surface toxicity.
Cardiovascular performance
As expected, cardiovascular effects in SHRs at high levels
of PM2.5-AB were small and would, as a single event be
clinically not relevant among subjects with adequate cardi-
ovascular reserves, or even not in patients with cardiac dis-
eases. However, triggering effects by repeated exposures
over several years as given in the environmental setting of
Augsburg may be one major factor contributing to the
Table 1 Representation of the response pattern (dose and time) of all the markers analyzed in lung and heart tissue
following instillation of 500 μg and 1000 μg Augusburg dust in Spontaneously hypertensive rats (SHRs)
Protein Lung Heart
Day1 Day3 Day1 Day3
500 μg 1000 μg 500 μg 1000 μg 500 μg 1000 μg 500 μg 1000 μg
Interleukin 6 (IL-6) 2.5 fold↑ 4.0 fold↑ n.s n.s n.d n.d n.d n.d
Osteopontin (SPP1) n.s 2.0 fold↑ n.s n.s n.s n.s n.s 2.4 fold↑
Macrophage inflammatory protein 2 (MIP2) n.s 1.3 fold↑ n.s 1.3 fold↑ n.s 1.5 fold↑ n.s 2.0 fold↑
Tumor necrosis factor alpha (TNFa n.s n.s n.s n.s- n.s n.s n.s n.s
Angiotensin converting enzyme (ACE) n.s 1.3 fold ↓ n.s 3.0 fold ↓ n.s 1.4 fold ↑ n.s 1.4 fold ↑
Endothelin 1 (ET1) 1.5 fold↓ 1.5 fold ↓ 1.5 fold ↓ 1.5 fold ↓ n.s 1.5 fold ↑ 1.5 fold ↑ 2.1 fold ↑
Plasminogen activator inhibitor 1 (PAI-1) 1.5 fold ↑ n.s 2.4 fold↓ 6.5 fold ↓ n.s n.s n.s 2.0 fold ↑
Tissue factor (TF) 1.5 fold↓ 1.5 fold ↓ 1.5 fold ↓ 1.5 fold ↓ n.s n.s n.s 2.0 fold ↑
Vascular cell adhesion molecule 1 (VCAM1) 1.3 fold↑ n.s n.s n.s n.s n.s n.s 1.6fold ↑
Vascular endothelial growth factor (VEGF) n.s 1.5 fold ↑ n.s n.s n.s n.s n.s n.s
n.d: not detected; n.s: not significant.
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epidemiological associations. The response in SHRs at
high levels of PM2.5-AB was characterized by a 5% increase
in mBP in exposed animals between the 2
nd -4
th post
exposure days the maximum being on 4
th day after instilla-
tion. Changes in mBP were due to a moderate changes in
systolic and diastolic BP. HR decreased by about 6% on
the 3
rd day after instillation. However, the statistical ana-
lyses were not definitely decisive for these cardiovascular
effects so that they have to be interpreted with caution
and the results valued in context with the effects detected
for markers of vascular homeostasis. In other experimental
settings moderate HR and BP changes have repeatedly
been reported in response to different PM [44-47] such as
an increased HR and BP in SHRs exposed to ultrafine
carbon particles [45] but also a decreased HR in response
to highway aerosols [44]. The direction and time point of
HR and BP differed between studies as the PM composi-
tion and fraction used suggesting that the cardiovascular
response to ambient particle may result from a summation
of temporally different effects of PM-associated compo-
nents including direct interaction of translocated particles
to pulmonary and systemic tissues [48,49]. The BP
changes observed in the present study are in line with the
epidemiological findings revealing a slight increased arter-
ial BP in response to elevated levels of Augsburg PM [25],
in particular in compromised subjects with high plasma
viscosity levels. However, changes in epidemiological stu-
dies were detected at an earlier time point than in our
experimental setting and HR rather increased than
Figure 8 A schematic summarization of the results obtained from Augsburg dust exposures in spontaneously hypertensive rats
(SHRs) in different organs are presented. BALF: Bronchoalveolar lavage fluid; IL-6: Interleukin-6; MIP-2: Macrophage inflammatory protein-2;
ACE: Angiotensin converting enzyme; ET-1: Endothelin-1; PAI-1: Plasminogen activator inhibitor-1; TF: Tissue factor; VCAM-1: Vascular cell
adhesion molecule-1 and VEGF: Vascular endothelial growth factor.
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account for this, such as randomly selected population
versus rats with distinct cardiovascular disease, species dif-
ference, route of PM exposure and particle translocation
kinetics, but at hand it is beyond the scope of the present
study to provide an obvious explanation.
Pulmonary and systemic inflammatory responses
A single Intratracheal instillation of PM2.5-AB was asso-
ciated with a low grade dose-dependent pulmonary
inflammation as indicated by accumulation of particle-
laden macrophages, lymphocytes, and PMNs resulting in
a 2-fold induction of total cell numbers in BALF on the
1
st day post instillation. This cellular response was
resolved within 3 days. In contrast, PM mediated in vivo
toxicity screening studies in SRHs by Gerlofs-Nijland
et al [36] reported a tremendous increase in PMN num-
ber in BALF 24-hr after exposure to the highest concen-
trations (10 mg/kg bw i.t.) of EHC-93 (urban dust from
Ottawa, Canada) or PM10 sampled nearby a road tunnel.
This suggests that PM from Augsburg has less inflam-
matory potential and that the severity of health effects
induced by PM from different sampling sites differs sub-
stantially between sites most likely due to differences in
chemical composition and the relative share of the parti-
cle size fractions at the different sites.
The dose-dependent induction of the proinflammatory
cytokine (IL-6) and the matricellular (matrix+cytokine:
osteopontin; [50]) protein in BALF confirm the PM2.5-
AB mediated pulmonary inflammation. Corresponding
observations were made in the epidemiological studies
in Augsburg [34,51] and have also been reported in
other studies [30,52].
Panel and population studies have associated elevated
PM levels with evidence of an acute-phase response
inferred from increased serum CRP levels [20], enhanced
plasma viscosity [17] and altered hematologic indices
[32,33,53,54]. Epidemiological findings [34,51] have sug-
gested that the increased level of IL-6 following high ambi-
ent PM load possible leads to the production of acute
phase proteins like CRP. This fits to observation made in
the present study where peak IL-6 concentrations in the
BALF were observed on the 1st day after instillation of
PM2.5-AB and highest CRP concentrations in serum after
the 3rd day. In a recent study Zhao et al. [55] have
reported that the levels of CRP in serum were significantly
higher in SHRs than those in WKY following instillation
of fine particle (8 and 40 mg/kg; collected from Shanghai,
China) supporting the notion that individuals with persist-
ing cardiopulmonary disorder are at higher risk when
exposed to the elevated level of PM than healthy ones.
Serum CRP concentrations reflect the burden of vas-
cular inflammation. In the presence of an intercurrent
illness or an exogenous inflammatory stimulus, serum
CRP concentrations increase rapidly as part of the
systemic acute-phase reaction [56,57]. In recent years
CRP has also come up as a leading biological marker of
atherosclerosis, with serum CRP concentrations, even at
very low levels, predicting the risk of acute myocardial
infarction or stroke in apparently healthy individuals
[34,57]. CRP seems to be a strong predictor of cardio-
vascular events in humans. Using widely available high-
sensitivity assays, CRP levels of <1, 1 to 3, and >3 mg/L
correspond to low-, moderate-, and high-risk groups for
future cardiovascular events in human [58]. We are not
aware of such grading for rodents. But if we extrapolate
from the available information in humans, a ~4 fold
induction of serum CRP on the 3rd day post instillation
of 1000 μgP M 2.5-AB suggests high risk for cardiovascu-
lar impairment in SHRs.
The time and dose dependent induction of MIP-2 and
osteopontin in cardiac tissue suggests that the PM2.5-AB
mediated sustained systemic inflammatory response also
involves cardiac tissue. Although cellular mechanism of
systemic inflammation are very complex, a number of
researchers reported that the induction of chemokine
(MIP-2) and the upregulation of matricellular protein
(ostopontin) are involved in the recruitment and stimu-
lation of neutrophil, macrophage, and lymphoctes after
particle exposure [59].
The present findings are consistent with a series of
studies suggesting that intratracheal instillation of PM in
rodents caused pulmonary and systemic inflammation
[60-63]. Effect of pulmonary PM exposure by inhalation
may be with/without systemic inflammatory response
[45]. This is mainly due to the lower dosage delivered to
the lungs over a longer period but the observed effect
also depend on the chemical composition, presence of
water-soluble metals and surface area of the particles as
shown in various studies [62-64].
Responses affecting vascular homeostasis
Potential pathways linking the observed pulmonary and
systemic events are identified by analysis of various bio-
markers associated with hypertension (ACE), endothelial
activation (ET-1), coagulation factors (TF; PAI-1), ather-
osclerosis (VACM-1) and angiogenesis (VEGF) from
pulmonary and cardiac tissues. Protein analysis of these
markers in cardiac tissues revealed a delayed systemic
response while the same markers responded differently
or to a lesser extent in pulmonary tissues. This result
illustrates the PM2.5-AB-specific differences in the
degree and time course of pulmonary and cardiac
effects. Studies from Wallenborn et al. [64] support our
observation. They specifically addressed the differential
pulmonary and cardiac effects of intratracheal instilled
metals in WKY rats (1 micromol/kg body weight of
zinc, nickel, vanadium, copper, or iron in sulfate form).
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the time point of pulmonary inflammation varied. Simi-
larly, the systemic effects noted for zinc, nickel or cop-
per occurred at different time points.
In pulmonary tissue a transient and early induction of
PAI-1, VEGF, and VCAM-1 and a decline in ACE,
ET-1, and TF concentrations suggests direct involve-
ment of the pulmonary vasculature in the PM2.5-AB
response. Reduced ACE and ET-1 levels may indicate a
vasodilation response as similar to the other studies
[65,66]. Increased expression of PAI-1 in the vasculature
has been recognized as indicator of disturbed endothe-
lial function [67] and associated with the progression of
atherosclerotic lesions [68,69]. Many studies have
shown that alteration of the VEGF homeostasis is
involved in different pathological states of pulmonary
tissues, such as acute lung injury and pulmonary arterial
hypertension [70,71]. A moderate upregulation of VEGF
- as observed in our study - is often regarded as a pro-
tective mechanism to restore tissue homeostasis because
VEGF serves as a survival and differentiation factor for
pulmonary endothelial cells [70,72]. Up-regulation of
VCAM-1 in the pulmonary tissue might be due to the
activation of endothelial cell by cytokines released from
activated macrophages or recruited PMNs [70]. Differ-
ent studies [73-75] have provided evidence that VCAM-
1 promotes the progression of atherosclerosis by accu-
mulation, adhesion and trans-endothelial migration of
leukocytes. Furthermore, activated endothelial cells can
increase the expression of PAI-1, VEGF and VACM-1
[70,76] and might be responsible for development of
atherosclerosis lesion.
Interestingly, in the heart all measured markers (except
VEGF) were increased at high concentrations on day
3 post exposure. The observed increased levels of PAI-1,
known to be an inhibitor of fibrinolysis and regulator of
vasoactivity, have been recognized as indication of
impaired endothelial function [67]. The additionally
observed induction of TF, the extrinsic coagulation path-
way, is highly correlated with thrombogenesis and
endothelial dysfunction [77,78]. Therefore activation of TF
in association with impaired fibrinolysis via PAI-1 activa-
tion following PM2.5-AB exposure supports the notion of
endothelial dysfunction, which is importantly correlated
with overall cardiovascular risk [77,79]. Endothelial dys-
function by PM in cardiac tissue can be further inferred
from induction of ET-1 and activation of the ACE system
in cardiac tissue following instillation of high PM2.5-AB.
Interestingly, the slight increase in BP follows the kinetics
of ACE and ET-1 concentrations in serum. ACE and other
components of the RAS (including rennin and angiotensin
II receptor) are expressed in the several organs (e.g. lung,
heart, brain) and play a significant role in the regulation of
systemic BP and endothelial homeostasis. Several studies
reported that RAS system plays a key role in ET-1 expres-
sion and might also be responsible for up-regulation of
ETB receptors [80,81]. Overall, PM2.5-AB exposure at high
concentration affects different endpoints of the vascular
homeostasis in the lungs and the systemic circulation by
triggering pathways known to be involved in endothelial
dysfunction, vasoregulation, and thrombogenesis.
In this study physiological parameters like HR and
HRV responded differently compared to our previous
ultrafine carbon particle inhalation study in SHRs [45].
Additionally we detected alteration at molecular level to
be more pronounced in cardiac tissue compared to pul-
monary tissue previously. This may be related to the dif-
ferent age groups (12 months versus 6 months) of
animals investigated and plausibly because of the altered
organ functions due to hypertension. But it’s more likely
that beside carbon particles other ambient PM2.5 com-
ponents from Augsburg are involved in the observed
systemic response [82]. Chemical analysis of PM from
Augsburg urban area reported the presence of anthropo-
genic polycyclic aromatic hydrocarbons (PAH) and their
oxidised derivatives (O-PAH, 40-43). Concentrations of
P A Ha n dO - P A Hi nP Mw e r eh i g h l yc o r r e l a t e dt oR O S
formation, which is known to be involved in inflamma-
tory responses in the lungs and extrapulmonary organs
[83]. Beside that PM2.5-AB contains various transition
metals which may move as soluble components directly
through the pulmonary vasculature and reach the sys-
temic circulation where the metals exert direct effects
on extrapulmonary tissue [62,64].
Conclusion
Although there are some differences between the effects
observed in our animal study and the effects detected by
epidemiological studies in Augsburg, overall, there is
clear evidence that many different pathways are trig-
gered in our model which play an important role in car-
diovascular impairment and fatal events. A schematic
summarization of the results obtained from Augsburg
dust exposures in SHRs in different organs are pre-
sented in Figure 8. The scheme mechanistically links the
observations obtained in this study as potential underly-
ing factors for the fatal cardiovascular events recognized
in epidemiological studies. As observed in many experi-
mental studies PM2.5-AB instillation induced a transient
inflammatory response in the lungs which was largely
resolved within 3 days. VEGF was moderately increased
presumably involved in restoration of lung tissue home-
ostasis, whereas continued effects are still observed in
the pulmonary vasculature. They were associated with
coagulation activity and vasoregulatory pathways includ-
ing the renin-angiotensin system. Secondary systemic
effects were characterized by a delayed, low grade sys-
temic inflammatory response not only involving the
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(Osteopontion, MIP-2). Through the induction of the
coagulation cascade (PAI-1, TF, VCAM-1) and vasore-
gulatory activities (ACE, ET-1) PM2.5-AB transiently
augments the hypertension and may contribute to the
development and progression of atherosclerotic lesions.
These acute effects underpin the atherothrombotic con-
sequences of acute exposure to PM2.5-AB on cardiovas-
cular disease. Although the chronic exposure as missing
link is lacking and beyond the scope of the present
study it is reasonable to consider effects of a single
exposure to be small and, taken as an unique event, to
be clinically of minor importance. However, repeated
exposures over several years as given in the environ-
mental setting of Augsburg is supposed to add up over
time [84] and promote cardiovascular disorders in sus-
ceptible-predisposed individuals, which may eventually
contribute to trigger fatal cardiac events such as myo-
cardial infarction documented in the epidemiological
studies (Figure 8).
Materials and methods
Sampling Location
The sample site was placed on the campus of the Uni-
versity of Applied Sciences Augsburg which is approxi-
mately 1 km to the south-east of the city centre. Within
a radius of 100 m it is surrounded by campus buildings,
a tram depot and a small company. The nearest main
road is in the north-east at a distance of 100 m. Within
a radius of approximately 200 m the monitoring site is
almost completely surrounded by residential areas, apart
from a small park located in north-western direction.
PM sampling
We used a High Volume Sampler (HVS, model DHA-80,
DIGITEL Elektronik AG, Switzerland) equipped with a
PM2.5 pre-separator (one-stage impactor certificated
according to EN12341) to collect PM2.5 samples on filters
(diameter 150mm). The flow rate of the HVS was adjusted
to 30 m
3/h and automatic regulated. After sampling the
filters were frozen at -20°C for further resuspension.
The sampling period started on the 18
th of September
2006 and ended on the 16
th of October 2006. In total 8
filters were available for an alternating sampling period
of 3 and 4 days.
Ambient concentrations (mass concentration of PM2.5,
number concentrations of ultrafine particles)
The mass concentration of PM2.5-AB was measured
using a tapered element oscillating microbalance
(TEOM, model 1400ab, Thermo Fisher Scientific Inc., U.
S.) equipped with a PM2.5 inlet. To correct the PM mea-
surement for aerosol volatility effects, the TEOM was
equipped with a filter dynamics measurement system
(FDMS, model 8500b, Thermo Fisher Scientific Inc., U.
S.).
The UFP number concentration was calculated from
the particle size distribution measured with a twin dif-
ferential mobility particle sizer (TDMPS) system. The
TDMPS system consists of two subsystems covering
different size ranges.
Details on the used online measurement devices and
further information about other continuously measured
physical and chemical parameters were already pub-
lished by Pitz et al. [38,39].
Animals
Male spontaneously hypertensive rats (SHR) were used
for the present study. Animals were housed under fil-
tered air and specific pathogen free (SPF) conditions at
a mean temperature of 22 ± 2°C, a mean relative humid-
i t yo f5 0±5 % ,a n da1 2hl i g h t - d a r kc y c l e( 6a . m .t o
6 p.m. light on) with pelleted feed and filtered water
being supplied ad libitum. Experimental protocols were
approved by the Animal Care and Use Committee of
the HelmholtzZentrum München - German Research
Center for Environmental Health and by the Bavarian
Animal Research Authority (211-2531-88/2007). Ani-
mals were 12-months of age with body weights between
360-380 g during the study.
Intra-tracheal instillation study
To assess the inflammatory response following instilla-
tion of ambient particle two animal groups were used.
In this study 1 year old male SHRs of Group A (Sham/
exposed: n = 8/8; Table 2) were IT-instilled with either
pyrogene-free distilled water (sham) or water suspension
of ambient particle (PM2.5-AB) at 250 μg, 500 μga n d
1000 μg under isoflurane anaesthesia and lavage were
performed at 24 h or day 1 postinstillation. Similarly
Group B (Sham/exposed: n = 8/8; Table 2) animals were
IT-instilled either pyrogene-free distilled water (sham)
or water suspension of ambient particle (PM2.5-AB) at
500 μg and 1000 μg under isoflurane anaesthesia and
lavage were performed at 72 h or day 3 postinstillation.
Additionally we have performed cardiovascular response
study following instillation of pyrogene-free distilled
water (sham; n = 5) and 1000 μg of particle (exposed;
n = 5), as inflammatory response were more pro-
n o u n c e da t1 0 0 0μg. For intra-tracheal instillation SHRs
were anesthetized by administration of isofluran (5.0%
isoflurane in O2; Sigma Delta Vaporizer; Uno, Zevenaar,
Netherlands) using a customized flow-through mask
(Helmholtz-Zentrum München, Neuherberg, Germany).
The animals were then intubated by a nonsurgical tech-
nique [85] using a bulb headed cannula inserted 10 mm
into the trachea; 250 μl of a suspension containing 250,
500 and 1000 μg particles, respectively, in pyrogene-free
distilled water was instilled individually in each animal.
The suspension of particles was sonicated for 1 min
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Plus HD70 (Bachofer, Berlin, Germany) at a moderate
energy of 20 W. We favour the use of pyrogene-free dis-
tilled water for suspension of particles because the salt
content of phosphate-buffered saline (PBS) causes rapid
particle agglomeration comparable to the “salting-out”
effect [63] and thus eliminates consistent instillation
conditions. Control (sham) animals were instilled with
pyrogene-free distilled water.
Assessment of ambient particle-mediated pulmonary
inflammatory response
BALF and lung BALF analysis was performed on day 1
(24h: group A) and day 3 (72h: group B) after instillation
as described in our previous study [45,86]. In brief, one ali-
quot of whole BALF (n = 6) was used for determining total
cell counts (Coulter Counter; Coulter, Inc., Miami, FL),
and a second aliquot was centrifuged (Cytospin 2; Shan-
don, Astmoor, UK) to counts cell differential. Macro-
phages, polymorphonuclear cells (PMNs, or neutrophil),
eosinophil, and lymphocyte were counted using light
microscopy (over 200 cells counted per slide). The remain-
ing BALF was centrifuged (1500 × g) to remove cells, and
the supernatant fluids were analyzed for osteopontin
(Catalog # 900-089; Biomol) and IL-6 (Catalog # 550319;
BD-Bioscience) concentration, as potential biological mar-
kers for pulmonary inflammation. Furthermore, transcript
profiling markers associated with pulmonary inflammation
(MIP-2, TNF-a), were also assessed at protein level from
the pulmonary tissues (n = 6) using the Rodent MAP™
version 2.0-custom 8-plex of the Rules Based Medicine
(Austin, Texas).
Pulmonary histopathology The left lung of each non
lavaged animal (n = 2) was infused via left main
bronchus by 4% buffered formalin at 20 cm water pres-
sure for 20-30 minutes. The main bronchus was then
tied and the lung was submerged in fixative until pro-
cessing for histology. Paraffin blocks were prepared
from dehydrated tissues and 3- to 4- μm sections were
stained with hematoxylin and eosin for light microscopic
evaluation of the pulmonary tissues [45,86]..
Assessment of ambient particle-mediated effects on
pulmonary and cardiac tissue
Protein analysis For protein analysis lung and cardiac
tissues were collected from each animals (n = 6) immedi-
ately after BALF collection, placed in vials and flash fro-
zen in liquid nitrogen. They were then stored at -80°C
until lung and heart tissue homogenates were prepared.
Pulmonary and Cardiac tissue homogenate prepara-
tion Total lung and heart homogenate was prepared
using 50 mM Tris-HCL with 2 mM EDTA, pH 7.4 as the
lysis buffer (1000 μl) from 6 animals/experimental group.
Using the Rodent MAP™ version 2.0-custom 8-plex of
the Rules Based Medicine (Austin, Texas) a panel of
inflammatory and biomarkers (protein) associated with
hypertension (ACE), endothelial activation (ET-1), coagu-
lation factors (TF; PAI-1), atherosclerosis (VACM-1) and
angiogenesis (VEGF) were analyzed from the lung and
heart homogenate. Lung and heart homogenate of the n
Table 2 Experimental design of cardio physiological, pulmonary and systemic response
Instillation
Adaptatiion Baseline Post exposure
Cardiovascular response Day -2 Day-1 Day 0 Night 1 Night 2 Night 3 Night 4 Night 5
Acclimatization √√√ √ √ √
Telemetry (n = 5)* No change BP BP BP BP BP BP
HR HR HR HR HR HR
ambient particle-mediated pulmonary and systemic response
Pulmonary resposne Day 1 (24 h; Group A) Day 3 (72 h; Group B)
Dose/rat 250 μg 500 μg 1000 μg 500 μg 1000 μg
BALF (n = 6) √√ √ √ √
Lung tissue (n = 6) √√ √ √ √
Pulmonary histopathology (n = 2) √√ √ √ √
Systemic response
Blood (n = 8) √√ √ √ √
Cardiac tissue (n = 6) √√ √ √ √
Cardiac histopathology (n = 2) √√ √ √ √
*Number of exposed animals is given. A similar number of animals were intratrachealy instilled with pyrogene-free distilled water and served as controls or
sham. Blood : blood collected from retro arbitral sinus and abdominal aorta.. BP and HR: blood pressure and heart rate were the two primary parameters
measured for the cardiovascular response.
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only the markers equal to/above (≥) the sensitivity level
were considered. Sensitivity level is the least detectable
dose (LDD) as provided by Rules Based Medicine. In all
cases a strong homogeneity of data were observed.
Osteopontin (SPP1) was also assayed from the heart
homogenate samples by ELISA (Catalog # 900089;
Biomol).
Cardiac histopathology The whole heart of each non
lavaged animal (n = 2) was submerged in fixative until
processing for histology. Paraffin blocks were prepared
from dehydrated tissues and 3- to 4- μm sections were
stained with hematoxylin and eosin for light microscopic
evaluation of the cardiac histopathology [86].
Assessment of ambient particle-mediated systemic response
Haematological analysis, measurement of different bio-
markers from plasma and serum were used for the assess-
ment of systemic response following PM2.5-AB exposure.
Blood samples of each animal were collected from retro
orbital sinus (haematology) and from abdominal aorta
(biomarkers) on day 1 and day 3 after instillation.
Haematology For haematological analysis, 500 μlo fb l o o d
sample from retro orbital sinus of each animal (n = 8) was
collected in EDTA-Microvette and analysed by using hae-
matology analyzer (Bayer ADVIA 120, Germany).
Acute phase proteins analysis Blood samples collected
from each animal (n = 8) were stored in aliquots of 2.6
ml in 2.9 ml S-Monovette®t u b e( S a r s t e d t ,G e r m a n y )
without anticoagulant for further analysis of biomarker.
C-reactive protein (CRP) was analysed from serum col-
lected from blood samples after centrifugation for 15-
minutes (at 1300g, 4°C). CRP was measured by ELISA
(Catalog#: 557825, Biomol). Furthermore, the markers
associated with systemic inflammation (MIP-2, TNF-a),
were also assessed at protein level from the cardiac tis-
sues (n = 6) using the Rodent MAP™ version 2.0-custom
8-plex of the Rules Based Medicine (Austin, Texas).
Cardiophysiological analysis by radiotelemetry
Exposure protocol
Cardiophysiological response prior to and following
instillation of ambient particle (1000 μg/rats) was per-
formed on 12 months old SHRs by using radio tele-
metric system as described in our previous study (86,
Dataquest A.R.T; Data Sciences International D.S.I.,
St. Paul MN, U.S.A). The implantation of telemetric
devices into the peritoneal cavity of animals was per-
formed as previously described [86]. All animals exhib-
ited rapid post surgical recovery, with resumption of
normal food and water intake within 24 h of surgery.
They returned to presurgical body weight (excluding the
weight of the implant) on average within 3-4 days and
did not exhibit any signs of post surgical complications.
After 10 days of post surgical recovery, 10 animals were
randomly assigned to the control (sham) or the expo-
sure group, respectively. Data recording was then
initiated and continued for six days, that included a
baseline reading (day 0), and post exposure period read-
ings (days 1-5) after instillation of pyrogene-free distilled
w a t e r( s h a m )o r1 0 0 0μg ambient particle (exposed,
Figure 2). In this study separate animal groups (n = 5)
were used for sham (instilled with water) and exposed
(instilled with 1000 μg particle) SHRs.
Animal preparation, data acquisition and analysis using
radio telemetry system
The implantation of telemetric devices into the peritoneal
cavity of animals (sham/exposed: n = 5/5), the radio tele-
metric data acquisition and analysis were performed as
described previously [45,86]. Briefly, arterial BP, HR, body
core temperature (T), and physical activity (Act)o fS H R s
were continuously collected over 24h/day, throughout
baseline and after instillation for 5 days. Systolic (sBP), dia-
stolic (dBP), and mean (mBP) arterial blood pressure were
determined from the BP tracings on a beat to beat basis.
The data of each animal were then processed to obtain
10-minutes average segments per rat for each of the mea-
sured parameters. For the final data analysis, we only have
considered the values of each parameter from the 12 h
dark period (6 p.m. to 6 a.m.), as animals are more active
during the night time. Thereby, 72 consecutive values of
10-minutes data segments were obtained per rat per day
and per parameter. Since we did not observe a time
dependency of particle associated effects during the 12 h
period in each of the exposed animals, mean values were
used for further data processing. For all of the measured
parameters, we averaged the 72 values obtained for each
day resulting in one mean value per parameter per rat and
per day. Based on these values, group mean were calcu-
lated on a daily bases for the whole study and were used
for statistical comparison between sham (pyrogene-free
distilled water) and exposed (1000 μg particle) SHRs.
For heart-rate variability (HRV) analysis, a different
procedure has to be applied [86]. For the 12 h dark peri-
ods, one 5-minutes ECG segment per hour was ran-
domly selected and used for further HRV analysis. For
each of these 5-minutes segments the standard deviation
of all adjacent normal sinus NN intervals (SDNN) was
determined as a measure of the overall HRV. In addi-
tion, the square root of the mean of squared differences
between adjacent normal to normal intervals (RMSSD)
and the low-frequency to high-frequency ratio (LF/HF),
reflecting the balance of cardiac parasympathetic tone
and sympathetic activity, respectively, were determined.
Further data processing to obtain daily averages for each
of the rats and group averages followed the procedure
described above for the other parameters.
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After checking for the normal distribution assumption
the differences between exposure and control (sham)
groups were compared by using the t-test. Cardiovascu-
lar response parameters were described by a linear
mixed regression model for repeated measurements.
Based on this model group differences between the
exposure and control group were tested. To assess
whether systematic BP and hear rate changes occur
after PM2.5 instillation area under the curve (AUC) sta-
tistics was applied as an summary indicator of systema-
tic changes for repeated measurements. For protein
analysis of various parameters from lung and heart tis-
sues, a two-way analysis of variance (ANOVA) was used
to analyze differences between the groups. P values less
than 0.05 were stated as statistically significant. All com-
p u t a t i o n sw e r ed o n eb yt h esoftware packages Stat-
graphics plus v5.0 (Manugistics, Rockville, MD) and
SAS V9.1 (Cary, NC). Data are presented as arithmetic
mean values of n observations ± the standard error (SE),
unless otherwise indicated.
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